[1]Dieter AA,Wilkins MF,Wu JM. Epidemiological Trends and Future Care Needs for Pelvic Floor Disorders[J].Curr Opin Obstet Gynecol,2015,27(5):380-384.
[2]Kerkhof MH, Hendriks L, Brlmann HA.Changes in connective tissue in patients with pelvic organ prolapse--a review of the current literature[J]. Int Urogynecol J Pelvic Floor Dysfunct,2009,20(4): 461-474.
[3]Cenizo V,André V,Reymermier C,et al.LOXL as a target to increase the elastin content in adult skin:a dill extract induces the LOXL gene Expression[J].Exp Dermatol,2006,15(8):574-581.
[4]Goepel C,Hefler L,Methfessel HD,et al.Periurethral connective tissue status of Postmenopausal women with genital prolapse with and without stress[J].Acta Obstet Gynecol Scand,2003,82(7):659-664.
[5]Lin SY,Tee YT,Ng SC,et al.Changes in the extracellular matrix in the anterior vagina of women with or without prolapse[J].Int Urogynecol J Pelvic Floor Dysfunct,2007,18(1):43-48.
[6]Zeng C,Liu J,Wang H,et al.Correlation Between Autophagy and Collagen Deposition in Patients With Pelvic Organ Prolapse[J].Female Pelvic Med Reconstr Surg,2018,24(3):213-221.
[7]Ewies AA,Al-Azzawi F,Thompson J.Changes in extracellular matrix proteins in the cardinal ligaments of post-menopausal women with or without prolapse: a computerized immunohistomorphometric analysis[J].Hum Reprod,2003,18(10):2189-2195.
[8]Moalli PA,Talarieo LC,Sung VW,et al.Impact of menopause on collagen subtypes in the arcus tendineous fascia pelvis[J]. Am J Obstet Gynecol,2004,190(3): 620-627.
[9]Ayers NB,Sun C,Chen SY.Transforming growth factor-b signaling in systemic sclerosis[J].J Biomed Res,2017. doi: 10.7555/JBR.31.20170034. [Epub ahead of print][1]0]Meijerink AM,van Rijssel RH,van der Linden PJQ.Tissue composition of the vaginal wall in women with pelvic organ prolapse[J].Gynecol Obstet Invest,2013,75(1):21-27. [1]1]Qi XY,Hong L,Guo FQ,et al.Expression of transforming growth factor-beta 1 and connective tissue growth factor in women with pelvic organ prolapse[J].Saudi Med J,2011,32(5):474-478.[1]2]Liu C,Wang Y,Li BS,et al.Role of transforming growth factor β-1 in the pathogenesis of pelvic organ prolapse: A potential therapeutic target[J].Int J Mol Med,2017,40(2):347-356. [1]3]Van Rooij E,Sutherland LB,Thatcher JE,et al.Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis[J].Proc Natl Acad Sci USA,2008,105(35):13027-13032.[1]4]Cushing L,Kuang PP,Qian J,et al.miR-29 is a major regulator of genes associated with pulmonary fibrosis[J]. Am J Respir Cell Mol Biol,2011,45(2):287-294.[1]5]Maurer B,Stanczyk J,Jungel A,et al.MicroRNA-29,a key regulator of collagen expression in systemic sclerosis[J]. Arthritis Rheum,2010,62(6):1733-1743.[1]6]Villarreal G Jr,Oh DJ,Kang MH,et al.Coordinated regulation of extracellular matrix synthesis by the microRNA-29 family in the trabecular meshwork[J]. Invest Ophthalmol Vis Sci,2011,52(6):3391-3397.